Neogen (NASDAQ:NEOG) Releases Earnings Results

Neogen (NASDAQ:NEOG) announced its quarterly earnings results on Thursday. The company reported $0.07 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.10 by ($0.03), Briefing.com reports. The company had revenue of $217.00 million for the quarter, compared to analyst estimates of $215.05 million. Neogen had a positive return on equity of 3.09% and a negative net margin of 1.02%. The firm’s quarterly revenue was down 5.2% on a year-over-year basis. During the same quarter last year, the company posted $0.11 earnings per share. Neogen updated its FY 2025 guidance to EPS.

Neogen Trading Up 4.6 %

Shares of NEOG stock opened at $14.43 on Friday. The company has a current ratio of 3.82, a quick ratio of 2.59 and a debt-to-equity ratio of 0.28. The stock has a market cap of $3.13 billion, a price-to-earnings ratio of -360.75 and a beta of 1.21. Neogen has a 1-year low of $11.46 and a 1-year high of $20.89. The stock has a 50-day moving average of $16.22 and a 200-day moving average of $15.19.

Insiders Place Their Bets

In other news, Director James P. Tobin acquired 3,000 shares of the firm’s stock in a transaction on Tuesday, August 6th. The stock was acquired at an average price of $16.86 per share, with a total value of $50,580.00. Following the completion of the purchase, the director now directly owns 23,392 shares in the company, valued at approximately $394,389.12. This trade represents a 0.00 % increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 1.13% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms have recently weighed in on NEOG. StockNews.com upgraded Neogen to a “sell” rating in a report on Monday, September 30th. Piper Sandler upped their price target on shares of Neogen from $17.00 to $17.50 and gave the company a “neutral” rating in a research report on Tuesday, August 6th.

About Neogen

Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods.